PARP inhibitor BMN673, Purity ≥98%

Cat. No.: X23-10-ZQ241

PARP inhibitor BMN673, Purity ≥98%

Synonym: 1207456-01-6; Talazoparib; BMN-673; BMN 673; BMN673; Talazoparib (BMN 673); Talzenna; PARP inhibitor

  • MDL: MFCD22666357
  • CAS Number: 1207456-01-6
  • Compound CID: 135565082
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMN673, soluble in warmed DMSO and insoluble in water and ethanol, binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks. It targets PARP.
Molecular Weight
380.35
Molecular Formula
C19H14F2N6O
Targets
PARP: 0.58 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 38 mg/mL (99.9 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BMN673 can be used to investigate its effects as a potent PARP inhibitor.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.